HOLX

Hologic
D

HOLX

64.750
USD
-0.45
(-0.69%)
مغلق
حجم التداول
77,653
الربح لكل سهم
4
العائد الربحي
-
P/E
27
حجم السوق
14,429,229,679
أصول ذات صلة
ABT
ABT
-0.770
(-0.56%)
135.620 USD
BDX
BDX
-2.215
(-1.27%)
172.245 USD
DGX
DGX
1.130
(0.63%)
180.170 USD
ISRG
ISRG
-0.86
(-0.17%)
511.99 USD
R
RGEN
-3.770
(-2.87%)
127.530 USD
SYK
SYK
-3.14
(-0.83%)
377.30 USD
T
TDOC
-0.32000
(-4.46%)
6.85500 USD
TMO
TMO
-12.61
(-3.04%)
402.69 USD
المزيد
الأخبار المقالات

العنوان: Hologic

القطاع: Healthcare
الصناعة: Medical Instruments & Supplies
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.